RAYMOND DIRADOORIAN

Corporate Board Profile

Tech Score: 0/100

LIFECORE BIOMEDICAL, INC. \DE\

Filing Date	Source Excerpt
2024-07-19	The Audit Committee consists of Mr. Edwards (Chairperson), Mr. Diradoorian, and Ms. Houde. In the determination of the Board, each of Mr. Edwards, Mr. Diradoorian, and Ms. Houde meets the independence requirements of the Securities and Exchange Commission (the “SEC”) and the Nasdaq Global Select Stock Market (“Nasdaq") applicable to members of the Audit Committee, including the heightened independence requirements for audit committee membership pursuant to SEC requirements, and each meets the financial literacy requirements of the SEC and Nasdaq applicable to members of the Audit Committee. The Board has also determined that each of Mr. Edwards, Mr. Diradoorian, and Ms. Houde is an “audit committee financial expert” within the meaning of applicable SEC rules. The Audit Committee assists the Board in its oversight of Company affairs relating to the quality and integrity of the Company’s financial statements, the qualifications and independence of the Company’s independent registered public accounting firm, the performance of the Company’s internal audit function and independent registered public accounting firm, and the Company’s compliance with legal and regulatory requirements. The Audit Committee is responsible for appointing, compensating, retaining, and overseeing the Company’s independent registered public accounting firm, approving the services performed by the independent registered public accounting firm and reviewing and evaluating the Company’s accounting principles and its system of internal accounting controls. The Audit Committee held seven meetings during fiscal year 2023. Compensation Committee: Craig Barbarosh, Raymond Diradoorian, Nelson Obus, Joshua E. Schechter (Chairperson). Effective as of the Annual Meeting date, the Compensation Committee will consist of Mr. Schechter (Chairperson), Mr. Obus, and Mr. Diradoorian. In the determination of the Board, each of Mr. Schechter, Mr. Diradoorian, and Mr. Obus meets the independence requirements of the SEC and Nasdaq applicable to members of the Compensation Committee. Compensation of Directors: Raymond Diradoorian $97,333 150,000 — $247,333
2024-09-23	The Audit Committee currently consists of Mr. Edwards (Chairperson), Mr. Diradoorian, Ms. Houde and Mr. Korenberg. ... The Compensation Committee consists of Mr. Schechter (Chairperson), Mr. Obus, and Mr. Diradoorian. ... Raymond Diradoorian $70,000 cash + $150,000 stock awards = $220,000 total compensation.

Filing Date

Source Excerpt

2024-07-19

The Audit Committee consists of Mr. Edwards (Chairperson), Mr. Diradoorian, and Ms. Houde. In the determination of the Board, each of Mr. Edwards, Mr. Diradoorian, and Ms. Houde meets the independence requirements of the Securities and Exchange Commission (the “SEC”) and the Nasdaq Global Select Stock Market (“Nasdaq") applicable to members of the Audit Committee, including the heightened independence requirements for audit committee membership pursuant to SEC requirements, and each meets the financial literacy requirements of the SEC and Nasdaq applicable to members of the Audit Committee. The Board has also determined that each of Mr. Edwards, Mr. Diradoorian, and Ms. Houde is an “audit committee financial expert” within the meaning of applicable SEC rules. The Audit Committee assists the Board in its oversight of Company affairs relating to the quality and integrity of the Company’s financial statements, the qualifications and independence of the Company’s independent registered public accounting firm, the performance of the Company’s internal audit function and independent registered public accounting firm, and the Company’s compliance with legal and regulatory requirements. The Audit Committee is responsible for appointing, compensating, retaining, and overseeing the Company’s independent registered public accounting firm, approving the services performed by the independent registered public accounting firm and reviewing and evaluating the Company’s accounting principles and its system of internal accounting controls. The Audit Committee held seven meetings during fiscal year 2023. Compensation Committee: Craig Barbarosh, Raymond Diradoorian, Nelson Obus, Joshua E. Schechter (Chairperson). Effective as of the Annual Meeting date, the Compensation Committee will consist of Mr. Schechter (Chairperson), Mr. Obus, and Mr. Diradoorian. In the determination of the Board, each of Mr. Schechter, Mr. Diradoorian, and Mr. Obus meets the independence requirements of the SEC and Nasdaq applicable to members of the Compensation Committee. Compensation of Directors: Raymond Diradoorian $97,333 150,000 — $247,333

2024-09-23

The Audit Committee currently consists of Mr. Edwards (Chairperson), Mr. Diradoorian, Ms. Houde and Mr. Korenberg. ... The Compensation Committee consists of Mr. Schechter (Chairperson), Mr. Obus, and Mr. Diradoorian. ... Raymond Diradoorian $70,000 cash + $150,000 stock awards = $220,000 total compensation.

Data sourced from SEC filings. Last updated: 2026-02-08